[HTML][HTML] Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind …

DJ Fu, I Turkoz, RB Simonson… - The Journal of …, 2014 - legacy.psychiatrist.com
Objective: Schizoaffective disorder is a complex illness for which optimal treatment is not
well established. Results of the first controlled, relapse-prevention study of paliperidone …

Scope-of-practice for nurse practitioners and adherence to medications for chronic illness in primary care

U Muench, C Whaley, J Coffman, J Spetz - Journal of general internal …, 2021 - Springer
Background Nonadherence to medications is costly and improving adherence is difficult,
requiring multifactorial solutions, including policy solutions. Objective The purpose of this …

Medication adherence, costs, and ER visits of nurse practitioner and primary care physician patients: Evidence from three cohorts of Medicare beneficiaries

U Muench, C Guo, C Thomas… - Health Services …, 2019 - Wiley Online Library
Objective To compare medication adherence, cost, and utilization in Medicare beneficiaries
attributed to nurse practitioners (NP) and primary care physicians (PCP). Data Medicare Part …

Association of medication adherence with hospital utilization and costs among elderly with diabetes enrolled in a state pharmaceutical assistance program

P Pednekar, DA Heller, AM Peterson - Journal of Managed Care & …, 2020 - jmcp.org
BACKGROUND: Medication adherence is crucial for the successful treatment among elderly
patients with diabetes taking oral antidiabetic medications (OAMs). Cost of medications, lack …

A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder

P Chue, J Chue - Therapeutics and clinical risk management, 2016 - Taylor & Francis
Schizoaffective disorder (SCA) is a chronic and disabling mental illness that presents with
mixed symptoms of schizophrenia and affective disorders. SCA is recognized as a discrete …

Paliperidone for the treatment of schizoaffective disorder

L Alphs, DJ Fu, I Turkoz - Expert opinion on pharmacotherapy, 2016 - Taylor & Francis
Introduction: Schizoaffective disorder (SCA) is a complex mental illness characterized by
psychosis and affective symptoms. Treatment usually involves concomitant therapy with …

[HTML][HTML] Treatment patterns and antipsychotic medication adherence among commercially insured patients with schizoaffective disorder in the United States

K Joshi, J Lin, M Lingohr-Smith, DJ Fu… - Journal of clinical …, 2016 - journals.lww.com
This study assessed real-world treatment patterns and antipsychotic (AP) medication
adherence among commercially insured US patients with schizoaffective disorder (SCA) …

[HTML][HTML] Paliperidone palmitate once-monthly maintains improvement in functioning domains of the Personal and Social Performance scale compared with placebo in …

DJ Fu, I Turkoz, D Walling, JP Lindenmayer… - Schizophrenia …, 2018 - Elsevier
Objective Evaluate the effect of paliperidone palmitate once-monthly (PP1M) injectable on
the specific functioning domains of the Personal and Social Performance (PSP) scale in …

[HTML][HTML] The long-term effects of hospitalization on health care expenditures: An empirical analysis for the young-old population in Lombardy

I Torrini, C Lucifora, AG Russo - Health Policy, 2023 - Elsevier
As the burden of acute care on government budgets is mounting in many countries,
documenting the evolution of health costs following patients' hospital admission is essential …

Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness

J Shafrin, K Bognar, K Everson, M Brauer… - ClinicoEconomics …, 2018 - Taylor & Francis
Background New digital technologies offer providers the promise of more accurately tracking
patients' medication adherence. It is unclear, however, whether access to such information …